About ST PHARM
ST PHARM is a company based in Siheung-si (South Korea) founded in 2008. The company has 664 employees as of December 31, 2024. ST PHARM offers products and services including CDMO Services, CRO Services, Oligonucleotide Services, and mRNA Services.
- Headquarter Siheung-si, South Korea
- Employees 664 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name St Pharm Co., Ltd.
-
Annual Revenue
$185.6 M (USD)-3.94as on Dec 31, 2024
-
Net Profit
$23.53 M (USD)77.27as on Dec 31, 2024
-
EBITDA
$35.95 M (USD)-1.91as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
664
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ST PHARM
ST PHARM is a publicly listed company on the KRX with ticker symbol 237690 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ST PHARM
ST PHARM offers a comprehensive portfolio of products and services, including CDMO Services, CRO Services, Oligonucleotide Services, and mRNA Services.
Contract development and manufacturing for pharmaceuticals and gene therapy.
Contract research and development for biotechnology and R&D projects.
Manufacturing and development of oligonucleotide-based therapies.
Contract production and research for mRNA technologies.
Funding Insights of ST PHARM
Investors in ST PHARM
ST PHARM has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include E&Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for ST PHARM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ST PHARM
Investment portfolio details for ST PHARM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ST PHARM
Detailed financials for ST PHARM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
St Pharm Comparisons
Peer comparison for ST PHARM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ST PHARM
Detailed competitors of ST PHARM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on St Pharm
Complete news archive for ST PHARM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ST PHARM
ST PHARM was founded in 2008 and raised its 1st funding round 7 years after it was founded.
ST PHARM is headquartered in Siheung-si, South Korea. It is registered at Siheung-si, Gyeonggi-do, South Korea.
As of Dec 31, 2024, the latest employee count at ST PHARM is 664.
Annual revenue of ST PHARM is $185.6M as on Dec 31, 2024.
Founded in 2008, ST PHARM functions as a contract development and manufacturing organization in the pharmaceutical sector. Services are extended across oligonucleotide, mRNA, and small molecule modalities, including research and development with virtual and global capabilities. Analytical testing and quality control are conducted to support clients from early-stage drug research to commercial production stages. Operations are based in South Korea.
ST PHARM offers CDMO Services, CRO Services, Oligonucleotide Services, and mRNA Services.
Yes, ST PHARM is publicly traded on KRX under the ticker symbol 237690.
ST PHARM has 1 investor. Key investors include E&Investment.
The ticker symbol of ST PHARM is 237690 on KRX.